A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target

被引:0
作者
Ji-li Xu
Yong Guo
机构
[1] Zhejiang Chinese Medical University,The First Clinical Medical College
[2] The First Affiliated Hospital of Zhejiang Chinese Medical University,Department of Medical Oncology
来源
Investigational New Drugs | 2022年 / 40卷
关键词
Pancreatic cancer; Expression; Prognosis; SIGLEC15; Immune escape;
D O I
暂无
中图分类号
学科分类号
摘要
Background. Pancreatic cancer (PC) is one of the most lethal cancer types with an extremely poor diagnosis and prognosis. This study aimed to comprehensively analyze the relationships between PC and different gene classes. Methods. Numerous genes from different categories were selected from the UALCAN database. Expression and survival analysis of these genes were performed via GEPIA, starBase and Kaplan–Meier Plotter tools. The correlations between PC-related genes and frequently mutated genes in PC as well as myeloid-derived suppressor cells (MDSCs) infiltration levels were explored by TIMER tool. The associations between PC-related genes, immune checkpoints and 182 core cancer-intrinsic CTLs-evasion genes were analyzed by R software. Besides, KEGG analysis were performed for the PC-related genes. Results. 14 genes were identified to be highly expressed in pancreatic cancer and significantly associated with poor prognosis. Besides, high expression of these genes were observed in patients with KRAS or TP53 mutations. Most genes were significantly positively associated with immune checkpoint SIGLEC15, however, showed negative relations to PDCD1, CTLA4, LAG3, TIGIT, PDCD1LG2. In addition, all 14 genes exhibited close relationships with MDSC infiltration levels and various core cancer-intrinsic CTLs-evasion genes, especially DNTTIP1, FADD, ARF6, BCL2L1, CEP55, GALE, PDCD6IP, and RCE1. We also explored the most related pathways with these genes to further reveal the pathogenesis and metastatic mechanisms of PC. Conclusion. Our study analyzed the relationships between 14 PC-related genes and pancreatic cancer from different angles, which may contribute to a better understanding of unsolved mystery in PC.
引用
收藏
页码:58 / 67
页数:9
相关论文
共 18 条
  • [1] A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target
    Xu, Ji-li
    Guo, Yong
    INVESTIGATIONAL NEW DRUGS, 2022, 40 (01) : 58 - 67
  • [2] T Lymphocytes: A Promising Immunotherapeutic Target for Pancreatitis and Pancreatic Cancer?
    Zhou, Qi
    Tao, Xufeng
    Xia, Shilin
    Guo, Fangyue
    Pan, Chen
    Xiang, Hong
    Shang, Dong
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [3] The ABCC4 gene is a promising target for pancreatic cancer therapy
    Zhang, Zhuo
    Wang, Jiancheng
    Shen, Baiyong
    Peng, Chenghong
    Zheng, Minhua
    GENE, 2012, 491 (02) : 194 - 199
  • [4] Comprehensive pan-cancer analysis reveals CDC6 as a potential immunomodulatory agent and promising therapeutic target in pancreatic cancer
    Pu, Dongyao
    Xu, Yingkun
    Yu, Haochen
    Yang, Ting
    Tang, Lingfeng
    Tan, Wenhao
    Zhang, Wenjie
    Liu, Shengchun
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (08) : 4096 - 4112
  • [5] Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy
    Zheng, Jialiang
    Miao, Fenglin
    Wang, Zhao
    Ma, Yuan
    Lin, Zhenhang
    Chen, Yaqin
    Kong, Xu
    Wang, Yue
    Zhuang, Aobo
    Wu, Ting
    Li, Wengang
    LIFE SCIENCES, 2023, 327
  • [6] Comprehensive analysis of the cuproptosis-related gene DLD across cancers: A potential prognostic and immunotherapeutic target
    Yang, Weiguang
    Guo, Qiang
    Wu, Haiyang
    Tong, Linjian
    Xiao, Jian
    Wang, Yulin
    Liu, Rui
    Xu, Lixia
    Yan, Hua
    Sun, Zhiming
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [7] Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
    Chen, Junliang
    Liu, Zhihao
    Wu, Zhiyuan
    Li, Wenjun
    Tan, Xiaodong
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Paper A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer
    Zhang, Shihang
    Qin, Ouyang
    Xu, Huanming
    Wu, Shu
    Huang, Wei
    Song, Hailiang
    AGING-US, 2023, 15 (24): : 14845 - 14863
  • [9] The reg4 Gene, Amplified in the Early Stages of Pancreatic Cancer Development, Is a Promising Therapeutic Target
    Legoffic, Aude
    Calvo, Ezequiel
    Cano, Carla
    Folch-Puy, Emma
    Barthet, Marc
    Delpero, Jean Robert
    Ferres-Maso, Montse
    Dagorn, Jean Charles
    Closa, Daniel
    Iovanna, Juan
    PLOS ONE, 2009, 4 (10):
  • [10] Pan-Cancer Analysis Reveals SOX2 as a Promising Prognostic and Immunotherapeutic Biomarker Across Various Cancer Types, Including Pancreatic Cancer
    Ding, Yuntao
    Wang, Huizhi
    Wang, Qiaowei
    Jiang, Han
    Li, Zhangzuo
    Yu, Zhengyue
    Wang, Qi
    Xu, Min
    JOURNAL OF CANCER, 2024, 15 (01): : 251 - 274